Effects of Oral Squamous Cell Carcinoma-derived TGF-β1 on CD26/DPPIV Expression in T Cells

Anticancer Research

Volumn 24, Issue 2 B, 2004, Pages 619-624

  Uematsu, Takashi ^a   Tanaka, Hitoshi ^a   Yamaoka, Minoru ^a   Furusawa, Kiyofumi ^a  

^a MATSUMOTO DENTAL UNIVERSITY   (Japan)

Author keywords

CD26; Squamous cell carcinoma; TGF 1, p27 kip; Tumor marker

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; PROTEIN ANTIBODY; PROTEIN P27; PROTEIN P27 KIP; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE G1 PHASE; CELL STRAIN KB; CELL SURFACE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; ENZYME ACTIVITY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; MOUTH CARCINOMA; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE;

ANTIGENS, CD26; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CHROMATOGRAPHY, AFFINITY; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; DOWN-REGULATION; HUMANS; KB CELLS; LYMPHOCYTE ACTIVATION; PROTEASE INHIBITORS; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 2442503748     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Yaron A and Naider F: Proline-dependent structural and biological properties of peptides and proteins. Crit Rev Biochem Mol Biol 28: 31-81, 1993.
2. Schön E, Demuth HU, Barth A and Ansorge S: Dipeptidyl peptidase IV of human lymphocytes. Evidence for specific hydrolysis of glycylproline p-nitroanilide in T-lymphocytes. Biochem J 223: 255-258, 1984.
3. Durinx C, Lambeir AM, Bosmans E, Falmagne JB, Berghmans R, Haemers A, Scharpe S and De Meester I: Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides. Eur J Biochem 267: 5608-5613, 2000.
4. Mogi M, Harada M, Hiraoka BY, Fukasawa K, Komatsu M and Nagatsu T: Sandwich enzyme-immunoassay for dipeptidyl aminopeptidase IV in the serum of people with oral cancer. Arch Oral Biol 31: 505-507, 1986.
5. Urade M, Komatsu M, Yamaoka M, Fukasawa K, Harada M, Mima T and Matsuya T: Serum dipeptidyl peptidase activities as a possible marker of oral cancer. Cancer 64: 1274-1280, 1989.
6. Urade M, Uematsu T, Mima T, Ogura T and Matsuya T: Serum dipeptidyl peptidase (DPP) IV activity in hamster buccal pouch carcinogenesis with 9,10-dimethyl-1,2-benzanthracene. J Oral Pathol Med 21: 109-112, 1992.
7. Uematsu T, Urade M and Yamaoka M: Decreased expression and release of dipeptidyl peptidase IV (CD26) in cultured peripheral blood T lymphocytes of oral cancer patients. J Oral Pathol Med 27(3): 106-110, 1998.
8. Eagle H: Propagation in a medium of a human epidermoid carcinoma, strain KB. Pro Soc Exp Biol Med 89: 362-364, 1955.
9. Urade M, Sugi M and Miyazaki, T: Establishment of three bleomycin-resistant human carcinoma cell lines and their cross-resistance to other antitumor agents. Cancer 61: 1501-1507, 1988.
10. Shirasuna K, Watatani K, Sugiyama M, Morioka S and Miyazaki T: Isolation and characterization of different clones including myoepithelial-like variants from a clonal neoplastic epithelial duct cell line of human salivary gland origin. Cancer Res 46: 1418-1426, 1986.
11. Hayashi Y, Yanagawa T, Yoshida H, Azuma M, Nishida T, Yura Y and Sato M: Expression of vasoactive intestinal polypeptide and amylase in a human parotid gland adenocarcinoma cell line in culture. J Natl Cancer Inst 79: 1025-37, 1987.
12. Danielpour D: Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor beta 1. J Immunol Methods 158: 17-25, 1993.
13. Brockmann JG, St Nottberg H, Glodny B, Heinecke A and Senninger NJ: CYFRA 21-1 serum analysis in patients with esophageal cancer. Clin Cancer Res 6: 4249-4252, 2000.
14. Yamamoto N, Naraparaju VR and Urade M: Prognostic utility of serum alpha-N-acetylgalactosaminidase and immunosuppression resulted from deglycosylation of serum Gc protein in oral cancer patients. Cancer Res 57: 295-299, 1997.
15. Game SM, Huelsen A, Patel V, Donnelly M, Yeudall WA, Stone A, Fusenig NE and Prime SS: Progressive abrogation of TGF-beta 1 and EGF growth control is associated with tumour progression in ras-transfected human keratinocytes. Int J Cancer 52: 461-470, 1992.
16. Sandhu C, Garbe J, Bhattacharya N, Daksis J, Pan CH, Yaswen P, Koh J, Slingerland JM and Stampfer MR: Transforming growth factor beta stabilizes p1SINK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells. Mol Cell Biol 17: 2458-2467, 1997.
17. Uematsu T, Urade M, Yamaoka M and Yoshioka W: Reduced expression of dipeptidyl peptidase (DPP) IV in peripheral blood T lymphocytes of oral cancer patients. J Oral Pathol Med 25: 507-512, 1996.
18. Dang NH, Torimoto Y, Deusch K, Schlossman SF and Morimoto C: Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways. J Immunol 144: 4092-4100, 1990.
19. Agarwal A, Rani M, Saha GK, Valarmathi TM, Bahadur S, Mohanti BK and Das SN: Disregulated expression of the Th2 cytokine gene in patients with intraoral squamous cell carcinoma. Immunol Invest 32: 17-30, 2003.
20. Pipataro L, Corsi MM, Sambataro G, Porcaro L, Tredici P and Broich G: Plasmatic cytokine network in patients with laryngeal carcinoma after surgical treatment. Anticancer Res 21: 3621-3625, 2001.